Bellevue Group’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-106,387
| Closed | -$9.94M | – | 163 |
|
|
2023
Q3 | $9.94M | Sell |
106,387
-127,931
| -55% | -$11.9M | 0.16% | 91 |
|
|
2023
Q2 | $21.4M | Sell |
234,318
-308,298
| -57% | -$28.2M | 0.31% | 75 |
|
|
2023
Q1 | $39.9M | Sell |
542,616
-70,896
| -12% | -$5.21M | 0.58% | 54 |
|
|
2022
Q4 | $51.3M | Buy |
613,512
+14,578
| +2% | +$1.22M | 0.68% | 47 |
|
|
2022
Q3 | $58M | Buy |
598,934
+13,780
| +2% | +$1.33M | 0.83% | 40 |
|
|
2022
Q2 | $61.5M | Buy |
585,154
+9,023
| +2% | +$948K | 0.87% | 39 |
|
|
2022
Q1 | $99.3M | Buy |
576,131
+86,119
| +18% | +$14.8M | 1.15% | 30 |
|
|
2021
Q4 | $79.3M | Buy |
490,012
+187,214
| +62% | +$30.3M | 0.82% | 39 |
|
|
2021
Q3 | $45.1M | Buy |
302,798
+242,311
| +401% | +$36.1M | 0.46% | 69 |
|
|
2021
Q2 | $14.8M | Hold |
60,487
| – | – | 0.14% | 116 |
|
|
2021
Q1 | $16M | Sell |
60,487
-10,703
| -15% | -$2.83M | 0.17% | 108 |
|
|
2020
Q4 | $20.9M | Buy |
71,190
+9,339
| +15% | +$2.74M | 0.24% | 98 |
|
|
2020
Q3 | $14.6M | Buy |
61,851
+708
| +1% | +$167K | 0.2% | 98 |
|
|
2020
Q2 | $12.1M | Hold |
61,143
| – | – | 0.17% | 98 |
|
|
2020
Q1 | $11.2M | Buy |
61,143
+7,778
| +15% | +$1.43M | 0.22% | 78 |
|
|
2019
Q4 | $8.91M | Sell |
53,365
-122,293
| -70% | -$20.4M | 0.14% | 98 |
|
|
2019
Q3 | $23M | Buy |
175,658
+1,348
| +0.8% | +$177K | 0.43% | 53 |
|
|
2019
Q2 | $21.2M | Buy |
174,310
+140,654
| +418% | +$17.1M | 0.36% | 56 |
|
|
2019
Q1 | $4.15M | Buy |
33,656
+8,452
| +34% | +$1.04M | 0.23% | 85 |
|
|
2018
Q4 | $2.95M | Hold |
25,204
| – | – | 0.19% | 89 |
|
|
2018
Q3 | $3.15M | Buy |
+25,204
| New | +$3.15M | 0.2% | 92 |
|